Pseudomonas aeruginosa-catecholamine inotrope interactions: a contributory factor in the development of ventilator-associated pneumonia?

Chest
Primrose P FreestoneChris O'Callaghan

Abstract

Ventilated patients receiving intensive care are at significant risk of acquiring a ventilator-associated pneumonia that is associated with significant morbidity and mortality. Despite intensive research, it is still unclear why Pseudomonas aeruginosa, a microbe that rarely causes pneumonia outside of intensive care, is responsible for so many of these infections. We investigated whether medications frequently prescribed to patients in the ICU, the catecholamine inotropes, were affecting the growth and virulence of P aeruginosa . Effects of clinically attainable concentrations of inotropes on P aeruginosa pathogenicity were explored using in vitro growth and virulence assays and an ex vivo model of infection using ciliated human respiratory epithelium. We found that inotropes were potent stimulators of P aeruginosa growth, producing upto 50-fold increases in bacterial numbers via a mechanism involving inotrope delivery of transferrin-ron,internalization of the inotrope, and upregulation of the key pseudomonal siderophore pyoverdine.Inotropes also markedly increased biofilm formation on endotracheal tubing and enhanced the biofilm production and toxicity of P aeruginosa in its interaction with respiratory epithelium.Importantly,...Continue Reading

References

Jan 1, 1992·Life Sciences·M Lyte, S Ernst
Jan 1, 1986·European Journal of Clinical Pharmacology·A MartinssonP Hjemdahl
Sep 1, 1993·Critical Care Medicine·M A SmytheC Dmuchowski
Jan 7, 1999·Intensive Care Medicine·R N JusteN Soni
Apr 16, 1999·European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery·J P ThompsonG Smith
Oct 6, 2000·Annual Review of Microbiology·C Ratledge, L G Dover
May 9, 2002·British Medical Bulletin·Julie C Brown
May 9, 2002·Proceedings of the National Academy of Sciences of the United States of America·Iain L LamontMichael L Vasil
Mar 22, 2003·The Journal of Pharmacology and Experimental Therapeutics·David S GoldsteinIrwin J Kopin
Jan 1, 2004·American Journal of Respiratory and Critical Care Medicine·Yochai AdirJacob Iasha Sznajder
Feb 3, 2007·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·N MesarosF Van Bambeke
May 15, 2007·Current Opinion in Infectious Diseases·Paula RamirezAntoni Torres
Jan 15, 2008·Trends in Microbiology·Primrose P E FreestoneMark Lyte
Feb 1, 2008·Pulmonary Pharmacology & Therapeutics·Sophie Moreau-MarquisGeorge A O'Toole
Feb 29, 2008·The New England Journal of Medicine·James A RussellUNKNOWN VASST Investigators
May 31, 2008·Neuroscience Letters·Christopher Liam O'CallaghanRobert Anthony Hirst
Jan 9, 2009·Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine·Iain L LamontDavid W Reid

❮ Previous
Next ❯

Citations

Jan 2, 2014·Scientifica·Primrose Freestone
Jan 21, 2014·Critical Care : the Official Journal of the Critical Care Forum·Girish B Nair, Michael S Niederman
Feb 14, 2016·Intensive Care Medicine·Davide Tommaso Andreis, Mervyn Singer
Nov 4, 2015·Annual Review of Physiology·Robert P DicksonGary B Huffnagle
Jul 1, 2015·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Gary B Huffnagle, Robert P Dickson
Sep 18, 2015·Annals of the New York Academy of Sciences·Leon Islas WeinsteinRogelio Hernandez Pando
Feb 26, 2015·Journal of Aerosol Medicine and Pulmonary Drug Delivery·Jaspreet Singh SahotaMartha Rebecca Jane Clokie
Oct 4, 2013·Microbiology·Sara SandriniPrimrose Freestone
Sep 4, 2015·Allergy, Asthma & Immunology Research·Sara SaturniAlberto Papi
Aug 26, 2014·Lancet·Robert P DicksonGary B Huffnagle
Jul 16, 2015·American Journal of Respiratory and Critical Care Medicine·Robert P DicksonGary B Huffnagle
Mar 21, 2015·The Journal of Endocrinology·Sara SandriniPrimrose Freestone
Dec 5, 2012·Brain, Behavior, and Immunity·Michael T Bailey
Jun 5, 2014·Journal of Critical Care·Zhongheng ZhangHongsheng Deng
Dec 25, 2015·The Lancet. Respiratory Medicine·Robert P Dickson
Feb 2, 2017·Journal of Intensive Care Medicine·Jason A Ferreira, Brittany D Bissell
Mar 14, 2014·The Lancet. Respiratory Medicine·Robert P DicksonGary B Huffnagle
Dec 15, 2016·Mucosal Immunology·G B HuffnagleN W Lukacs
Jan 31, 2018·Antimicrobial Agents and Chemotherapy·Paul G AmbroseChristopher M Rubino
Nov 20, 2016·Applied and Environmental Microbiology·Giannis KoukkidisPrimrose Freestone
Oct 27, 2018·The European Respiratory Journal·Robert P Dickson
Aug 29, 2019·Physiological Reviews·John F CryanTimothy G Dinan
Nov 2, 2017·American Journal of Respiratory and Critical Care Medicine·Robert P Dickson
Oct 30, 2019·American Journal of Respiratory Cell and Molecular Biology·Sharon M CarneyStavros Garantziotis
Oct 4, 2015·American Journal of Physiology. Lung Cellular and Molecular Physiology·Robert P DicksonGary B Huffnagle
Oct 28, 2017·Journal of Oncology·Rea BingulaEdith Filaire
Nov 1, 2017·Korean Journal of Critical Care Medicine·Ki Hoon KimCharles Her
Dec 19, 2019·Frontiers in Microbiology·Mohammed ImamEdouard E Galyov
Mar 16, 2018·Archivum Immunologiae Et Therapiae Experimentalis·Valerie F L YongSanjay H Chotirmall
Feb 15, 2019·The New England Journal of Medicine·Lionel A Mandell, Michael S Niederman
Jun 10, 2020·Critical Care : the Official Journal of the Critical Care Forum·Ekaterina ChernevskayaAlexander Tyakht
May 27, 2016·Microbiology Spectrum·Mark Lyte

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Related Papers

American Journal of Critical Care : an Official Publication, American Association of Critical-Care Nurses
Cindy L MunroCurtis N Sessler
Journal of Critical Care
John MuscedereVAP Guidelines Committee and the Canadian Critical Care Trials Group
© 2021 Meta ULC. All rights reserved